Journal of clinical anesthesia
-
Randomized Controlled Trial Multicenter Study
Use of sugammadex in patients with a history of pulmonary disease.
To evaluate the safety and efficacy of sugammadex for reversal of rocuronium-induced neuromuscular blockade in patients with pulmonary disease. ⋯ Sugammadex 2 mg/kg and 4 mg/kg were well tolerated and effective in patients with a history of pulmonary disease. Bronchospasm is a possibility when administering sugammadex to patients with underlying pulmonary disease.